#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Acute respiratory distress syndrome Glomerulonephritis chronic Cerebellar ataxia Chronic graft versus host disease in liver Fusarium infection Metastases to central nervous system Sexually transmitted disease Ductal adenocarcinoma of pancreas Complex regional pain syndrome C3 glomerulopathy Antiphospholipid antibodies Nasopharyngeal cancer Hereditary hypophosphataemic rickets B precursor type acute leukaemia Leukaemia More trials…

    Learn about Rare Diseases

    Loeys-Dietz syndrome – Trials in Disease Advanced systemic mastocytosis – Treatment Thrombotic thrombocytopenic purpura Hereditary ataxia – Diagnostics Small intestine leiomyosarcoma – Treatment Hepatic angiosarcoma – Life with Disease Leiomyosarcoma – Treatment Adrenogenital syndrome – Life with Disease Pleural mesothelioma malignant – Trials in Disease Acquired haemophilia – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    GSKVX000000034795 Flecainide Iptacopan Hydrochloride Resiniferatoxin Pal1-15 Acetate CIRTUVIVINT Lactose Ubamatamab PIPOTIAZINE Riociguat Finerenone Tepotinib Fusidic Acid Rosuvastatin Calcium Febuxostat Methoxsalen Dobutamine Itacitinib Eprosartan Mesilate Lacutamab More therapies…

    Learn about Your Condition

    Alcohol abuse Oral herpes Menopause Acute respiratory failure Huntington's disease Bronchitis Myocarditis post infection T-cell type acute leukaemia Juvenile spondyloarthritis Psoriasis Epileptic encephalopathy Lung cancer metastatic Haemofiltration Proteinuria Multifocal motor neuropathy More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • Comparing mirikizumab versus azathioprine with glucocorticoids in newly diagnosed patients with moderate-to-severe ulcerative colitis

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Azathioprine
    • Mirikizumab
    Germany

  • Comparison of ivabradine, atenolol, and metoprolol for heart rate control in patients with ischemic heart disease before cardiac CT examination

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Myocardial ischaemia
    Investigated Drugs:
    • Atenolol
    • Chlortalidone
    • Metoprolol Succinate
    Denmark

  • Study of semaglutide for weight loss in adults with type 1 diabetes and obesity

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Type 1 diabetes mellitus
    • Obesity
    Investigated Drugs:
    • Placebo
    • Semaglutide
    Denmark

  • Study of APAC (antiplatelet, anticoagulant) treatment in patients with peripheral arterial disease and chronic limb-threatening ischemia during blood vessel restoration procedure

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • UNFRACTIONATED HEPARIN, PORCINE, CONJUGATED WITH HUMAN SERUM ALBUMIN
    • Heparin Sodium
    • Sodium Chloride
    Finland

  • Safety and tolerability study of sodium hydrogen carbonate and sodium dihydrogen phosphate suppository treatment in adult patients with chronic constipation

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Constipation
    Investigated Drugs:
    • SODIUM DIHYDROGEN PHOSPHATE
    • Sodium Hydrogen Carbonate
    Germany

  • Study of semaglutide and finerenone for kidney and blood vessel protection in adults with chronic kidney disease, with or without diabetes

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Chronic kidney disease
    Investigated Drugs:
    • Finerenone
    • Semaglutide
    Denmark
Previous Page
1 … 164 165 166 167 168 … 1,648
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!